Active case

Toxic Exposure /

Hair Relaxer Lawsuit

Hair Relaxer Lawsuit

People diagnosed with uterine, endometrioid, or ovarian cancer after using hair relaxers are filing lawsuits. Learn about legal claims, affected products and case updates.

Connect with an attorney
Gavel and stethoscope

Case Overview

Hair relaxer lawsuits allege companies like L’Oréal and Revlon manufactured dangerous products that led to people developing cancer. Studies have linked hair relaxer chemicals to multiple types of cancer, including uterine, endometrial and ovarian cancer. Women who developed these cancers after using hair relaxers may be able to file a hair relaxer lawsuit.

Important hair relaxer lawsuit updates

  • June 2025: There were 10,317 lawsuits pending in the hair relaxer MDL.
  • February 2025: The court has established a comprehensive bellwether trial plan for the hair relaxer MDL.
  • January 2025: A hearing was scheduled for January 31, 2025, to discuss bellwether selection and the Court ultimately set deadlines regarding Bellwether discovery and trials.
  • October 2024: The court held a status hearing on October 10, 2024. During this hearing, the court ruled on discovery closure dates for 2025. Written discovery will close on February 28, 2025, and oral fact discovery will close on September 30, 2025.
  • October 2024: The Court entered an order referring all discovery disputes to Magistrate Judge Beth Jantz.

Learn about more hair relaxer lawsuit updates.

Key hair relaxer lawsuit takeaways

  • Hair relaxer lawsuits claim manufacturers failed to warn consumers about cancer risks associated with endocrine-disrupting chemicals.
  • Scientific studies suggest a connection between chemical hair straighteners and uterine, ovarian and breast cancer.
  • Plaintiffs in MDL 3060 proceedings seek compensation for medical bills, lost wages and pain and suffering.

Why are people filing hair relaxer cancer lawsuits?

People are filing hair relaxer cancer lawsuits because they or their loved ones developed cancer after being exposed to dangerous chemicals contained in these products. Many women use hair relaxers as a part of their normal self-care regimen. However, research and diagnoses have shown an increased risk of ovarian cancer, uterine cancer and endometrial cancer in frequent users of hair-relaxer products.

Hair relaxer lawsuits claim defendants: 

  1. Knew or should have known about the risks of hair-relaxing chemicals
  2. Marketed dangerous products without warning consumers
  3. Misrepresented the products as “safe” and “natural”
  4. Reinforced discriminatory standards of beauty and negative stereotypes about afro-textured hair

These lawsuits began after a 2022 study linked chemical hair relaxers to an increased risk of uterine cancer. The 2022 study used data from the National Institute of Environmental Health Sciences (NIEHS). The NIEHS is part of the National Institute of Health (NIH). 

Researchers found women who frequently used chemical hair straighteners were more than twice as likely to develop uterine cancer over those who did not. This study used data from a larger body of research called the Sister Study. The Sister Study followed 50,000 women for 10 years to study cancer and what might cause it. Earlier research had linked using these products to an increased risk of ovarian cancer. 

People began to file hair relaxer cancer lawsuits shortly after the 2022 NIEHS study was published. Motley Rice lawyers are currently evaluating potential cases involving these types of cancer:

  • Ovarian cancer
  • Uterine cancer
  • Endometrial cancer

These cancers have been connected with various chemicals present in hair relaxer products. If you believe you may have developed cancer from these chemicals, consider reaching out to the hair relaxer lawyers at Motley Rice.

Summary image discussing who is eligible to file a lawsuit, qualifying injuries, number of cases pending and brands involved in hair relaxer lawsuits.

What is the hair relaxer MDL?

Multidistrict litigation (MDL) for hair relaxer claims is currently proceeding in federal court. The MDL consolidates multiple chemical hair straightener lawsuits across the country. The MDL is against hair relaxer manufacturers over the alleged link between the use of hair relaxers and cancer diagnoses. 

As of June 2, 2025, 10,317 actions were pending in the hair relaxer MDL.

Motley Rice attorney Fidelma Fitzpatrick was appointed co-lead counsel for In re: Hair Relaxer Marketing Sales Practices And Products Liability Litigation, MDL No. 3060 in the U.S. District Court for the Northern District of Illinois. Motley Rice attorney Tope Leyimu is on the Leadership Development Committee and is co-chair of the L’Oréal Liability Committee.

Motley Rice attorneys Carmen Scott and Chelsea Monroe both serve on the Leadership Development Committee for the MDL, with Carmen serving as the Committee’s co-chair. 

Who is eligible to file a hair relaxer lawsuit?

Individuals may qualify to file a hair relaxer lawsuit if they meet the following criteria:

  • They regularly used chemical hair relaxers for several years
  • They were diagnosed with uterine, ovarian or endometrial cancer
  • Medical documentation linking exposure to the condition

A hair relaxer lawyer at Motley Rice can review specific case details and determine eligibility based on medical records and product history.

What is the average payout for a hair relaxer lawsuit?

There is no average payout for hair relaxer lawsuits, as none have settled or received court verdicts yet. Future settlements and verdicts will depend on multiple factors, including:

  • Severity of illness: More serious diagnoses, such as late-stage cancers, may result in higher compensation.
  • Medical expenses and treatment costs: Plaintiffs with extensive medical bills may receive larger settlements.
  • Length and frequency of hair relaxer use: Long-term use strengthens the case for causation.
  • Manufacturer liability and case strength: Stronger evidence linking a product to harm may increase settlement potential.

Since the hair relaxer MDL is ongoing, no payouts have been finalized. While past toxic exposure cases suggest settlements could range from thousands to millions of dollars, individual results will vary. No specific compensation amount or favorable outcome is guaranteed.

Contact a hair relaxer lawyer

If you or a loved one was diagnosed with ovarian cancer, uterine cancer or endometrial cancer after using a chemical hair relaxer product, know that you are not alone during this difficult time. For more information or to discuss a potential case, reach out to hair relaxer MDL attorneys. Call 1-800-768-4026 or email at any time.

Predatory marketing efforts of hair relaxer companies

The hair relaxer product market alone is worth hundreds of millions of dollars annually. In late 2024, this was expected to come out to around $719.88 million. That number is expected to grow to $889.83 million annually by 2029. Millions of dollars are at stake over one product category. For this reason, manufacturers have also poured millions of dollars into marketing.

Historically, Black and Brown hair textures have been discriminated against and devalued. Cosmetic companies have used branding and slogans to reinforce Eurocentric standards of beauty. But they haven't disclosed the full health effects of these products. 

Many defendants named in today’s lawsuits have been marketing their hair-relaxing products since the 1950s, 1960s and 1970s. As a result, brand loyalty has been passed down for decades. This has led to generations of Black and Brown women using these products long-term. 

Marketing to children misled consumers

In 1990, Godrej (a large multinational company) developed and began marketing "Just For Me" hair relaxer products. These products targeted children and young women with catchy commercials and colorful packaging. They used depictions of children and language about the “gentle” formula. Many defendants introduced similar product lines aimed at children.

Misleading language deceived consumers about safety

Hair relaxer manufacturers allegedly used misleading language on hair relaxer packages and advertisements. Below are a few examples. This is not an exhaustive list of allegedly misleading language on hair relaxer products.

  • Strength of Nature (owned by Godrej) labeled products such as Soft & Beautiful, with language like “Botanicals,” “Natural,” “Gentle” and “Ultra Nourishing.” It also marketed its Beautiful Textures hair relaxer product with the slogan “go from curly to straight and back again without using harsh chemicals!”
  • Soft Sheen (owned by L’Oréal) labeled its Dark & Lovely brand hair relaxer products as providing a “healthy” gloss and containing “nourishing” shea butter with jojoba and avocado oils.
  • Namaste (owned by Dabur) marketed its ORS Olive Oil relaxer as a way to “safely elongate tight coils.” 

Plaintiffs allege hair relaxer cancer lawsuit defendants have used misleading labeling and marketing. Whether they called their ingredients “safe,” “natural” or “nourishing,” they all failed to disclose the serious health risks posed to consumers.

Companies and products named in hair relaxer cancer lawsuits

Several cosmetic companies have been named in the lawsuits for hair relaxers. Some are standalone companies, and others are owned by larger parent companies. Companies involved in hair relaxer claims include: 

  • Avlon
  • Dabur International
  • Godrej SON Holdings
  • Beauty Bell Enterprises, LLC f/k/a House of Cheatham Inc.
  • House of Cheatham
  • AFAM Concept Inc. d/b/a JF Labs, Inc.
  • JF Labs
  • L’Oréal
  • Luster
  • McBride
  • Namaste Laboratories
  • PDC Brands
  • Sally Beauty
  • SoftSheen-Carson
  • Strength of Nature

These companies allegedly manufacture, market and sell dangerous chemical hair relaxer products. More defendants may be added as people continue to file lawsuits.

Potentially harmful hair relaxer products

These companies are responsible for using product ingredients that may increase cancer risk. Many hair relaxer brands and products are involved in these lawsuits. Some examples include:

  • Affirm®
  • African Pride®
  • Africa’s Best®
  • Cantu
  • Crème of Nature®
  • Dark & Lovely®
  • Design Essentials®
  • Dr. Miracle’s®
  • Dream Kids
  • Hawaiian Silky®
  • Just for Me®
  • Mizani®
  • Motions®
  • Optimum Care®
  • Organic Root Stimulator™
  • ORS Olive Oil™
  • Pink Conditioning No-Lye Relaxer®
  • Profectiv Mega Growth®
  • Revlon Realistic®
  • Roots of Nature®
  • Silk Elements®
  • Smooth Touch No-Lye Relaxer®
  • Soft & Beautiful®
  • TCB®
  • TCB Naturals®

Some companies, like L’Oréal, are responsible for multiple products. You may not be sure what company is responsible for a product you believe may have caused your cancer. A hair relaxer lawyer may be able to determine the responsible company.

Read about the alleged link between these hair relaxer products and cancer below.

The alleged link between hair relaxers and cancer

A growing body of scientific evidence has allegedly linked chemical hair relaxers to some reproductive cancers. Although many people use these chemical hair relaxer products, Black women are more likely to use them and may be at greater risk.

The NIEHS Sister Study provided data for several other studies. The studies illustrated the link between hair-relaxing chemicals and reproductive cancers. The NIEHS Sister Study was a decade-long study that followed 50,000 women aged 35 – 74. Some analyses of Sister Study data do not use the entire population of the study.

  • 2021 Sister Study analysis: This analysis looked at data from 40,559 Sister Study participants. It showed that women who used hair-relaxing products four or more times per year were more likely to develop ovarian cancer.
  • 2022 Sister Study analysis: This analysis looked at data from 33,497 Sister Study participants. It showed that women who used hair-relaxing products four or more times per year were twice as likely to develop uterine cancer.

About 60% of the study participants who reported using chemical hair relaxers were Black women. This study confirmed that these risks affect Black women more than others. 

How do hair relaxers cause cancer?

Hair relaxers may cause cancer because they include several potentially toxic chemicals. These potentially carcinogenic ingredients include but aren’t limited to:

  • Cyclosiloxanes
  • Di-(2-ethylhexyl)
  • Formaldehyde
  • Lye
  • Octamethylcyclotetrasiloxane
  • Parabens
  • Phthalates

Many of the ingredients in hair relaxers are known endocrine disruptors. Endocrine disruption is linked to reproductive cancers, including ovarian cancer, uterine cancer and endometrial cancer. 

Several EDCs and carcinogens have been found in hair relaxers. Consistent exposure can lead to endocrine disruption and the development of cancer over time. For example, one chemical alleged to cause damage is formaldehyde. 

In December 2024, the Environmental Protection Agency (EPA) released its final risk evaluation under the Toxic Substances Control Act. The evaluation determined that formaldehyde presents an unreasonable risk of injury to human health. The agency noted the risk may be higher for people who use products with formaldehyde. Repeated inhalation is linked to serious health issues, such as cancer and reduced lung function.

In addition, the FDA proposed a ban on formaldehyde and formaldehyde-releasing chemicals in hair relaxers in 2024, with regulatory action expected later in the year. However, the agency delayed the rule’s release several times and ultimately took no action last year.

Community forum discusses chemical hair relaxer impact on health

Tope Leyimu participated in a community forum discussing the possible health risks chemical hair relaxers may have on women’s health. The panel discussed recent scientific studies and the alleged link between the increased risk of developing certain cancers after using these products. Watch more from CBS News.

Important terms

  • Endocrine system: This bodily system creates and releases hormones. It regulates physical growth and development. The endocrine system also regulates other systems, including the nervous system, reproductive system and metabolism.
  • Endocrine disruption: Interference with the endocrine system’s natural function, this includes stopping or increasing hormone production and producing hormones when they’re not needed.
  • Endocrine-disrupting chemicals (EDCs): These are chemicals and mixtures that hinder the normal activity of the endocrine system. They can block hormone signals by modifying DNA and cell structure.
  • Reproductive cancers: These are cancers affecting the reproductive organs. For women, these cancers include cervical cancer, ovarian cancer, uterine cancer, vaginal cancer, vulvar cancer and breast cancer. Endometrial cancer is a type of uterine cancer.

Hair relaxers and uterine and endometrial cancer

In 2024, the Journal of the National Cancer Institute published a study that found an increased risk of uterine cancer in women who use chemical hair relaxers and straighteners.  The study linked endocrine-disrupting chemicals (EDCs) in hair relaxers to higher rates of aggressive uterine fibroids and ovarian cancer. Black women were affected more than other groups

Endometrial cancer begins in the lining of the uterus, called the endometrium. Endometrial cancer often causes symptoms early on. This can, thankfully, lead to early diagnosis and treatment. However, the primary treatment for endometrial cancer is a hysterectomy. A hysterectomy is a surgical procedure that removes the uterus and cervix. Women who require this procedure may be eligible for a hair relaxer hysterectomy lawsuit.

Hormonal change is one of the biggest risk factors for endometrial cancer and uterine cancer. Changes in hormones affect the reproductive organs drastically. 

Endometrial cancer symptoms 

  • Bleeding between periods
  • Pelvic pain
  • Vaginal bleeding after menopause

Contact your healthcare provider for a screening if you experience any of these symptoms.

Hair relaxers and uterine and ovarian cancer

The same study also found that endocrine-disrupting chemicals (EDCs) in chemical hair relaxers are associated with a higher risk of ovarian cancer. Researchers noted that Black women are disproportionately exposed to these harmful chemicals. They have historically been the primary consumers of these products because of societal beauty norms about hair. 

Ovarian cancer can be hard to diagnose early because symptoms are often downplayed. Many symptoms may present similarly to other common conditions. However, cancer cells can grow quickly. It is important to contact your doctor if you experience ovarian cancer symptoms.

Ovarian cancer symptoms include:

  • Abdominal bloating or swelling
  • Back pain
  • Changes in bowel habits, including constipation
  • Fatigue
  • Frequent urination
  • Pelvic discomfort
  • Quickly feeling full when eating
  • Weight loss

A change in hormones is a risk factor for ovarian cancer. 

Hair relaxer lawsuit update timeline

06.03.25

June report showed MDL growth

The hair relaxer MDL increased to 10,317 pending actions as of June 2.

05.02.25

MDL numbers increased leading into May

The hair relaxer MDL increased to 10,168 pending actions.

04.02.25

April report showed MDL growth

There were 9,936 pending actions in the hair relaxer MDL.

03.03.25

March MDL numbers dipped

The hair relaxer MDL had 9,788 pending actions.

02.04.25

MDL continued to grow in February

9,863 actions were filed and pending in the hair relaxer MDL as of February, 3.

01.07.25

Hearing set for bellwether case selection

A January 31, 2025, date was set to hold a hearing about bellwether case selection. Cases filed and served before February 1, 2024, were declared potentially eligible for bellwether selection. A bellwether trial may help determine how other trials are run in the multidistrict litigation (MDL). The Court issued an order following the January 31 hearing that set deadlines regarding bellwether discovery and trial.

01.03.25

More suits filed in the hair relaxer MDL

The hair relaxer MDL grew to 9,819 actions pending as of January 2, 2025.

12.01.24

New cases added to the MDL

The hair relaxer MDL continued to grow as more people file new lawsuits. The total number of active cases was 9,649.

11.01.24

Hair relaxer MDL adds more cases

Plaintiffs continued to file hair relaxer product lawsuits, bringing the total number of cases in the docket to 9,488 at the start of November.

10.10.24

Discovery deadlines set

On October 10, 2024, the court held a status hearing and ruled on discovery closure dates for 2025. Written discovery will close on February 28, 2025, with oral fact discovery concluding on September 30, 2025.

10.01.24

Hair relaxer MDL continues to grow

In October, the hair relaxer MDL contained 8,393 cases. Individuals and their families who have developed a qualifying condition as a result of using hair relaxer products may still be able to join the MDL.

09.30.24

Class action to proceed

In September 2024, Judge Mary Rowland determined that a proposed class action lawsuit against hair relaxer manufacturers could proceed. It concerns plaintiffs seeking reimbursement for using allegedly dangerous hair relaxer products. Plaintiffs in the class action say they wouldn’t have purchased the hair relaxers if they had known of the associated dangers. This class action differs from the individual lawsuits filed by people who have developed various cancers connected to hair relaxers.

09.01.24

More cases added to MDL through August

The September hair relaxer MDL had north of 8,000 actions pending, marking an increase of over 500 cases from August.

08.01.24

Small decrease in cases included in hair relaxer MDL

The hair relaxer MDL shrank to 7,946 actions. Despite this decrease, new claims could still be filed in the Northern District of Illinois.

07.01.24

Hair relaxer MDL grows

The hair relaxer MDL grew to 8,192 actions pending as of July 1, 2024. This meant 22 more actions were filed in the previous month alleging that hair relaxers have caused cancer in women.

06.01.24

New Special Master appointed in MDL

Professor Maura Grossman was appointed Special Master on Electronically Stored Information (ESI) discovery disputes for MDL No. 3060. Professor Grossman’s appointment came over objections raised by the defendants. Judge Rowland could still continue to rule on discovery disputes.

06.01.24

June 2024

Over 8,000 actions were pending in the hair relaxer MDL as of June 3, 2024. The year started with 8,026 actions pending. Pending actions refer to the number of individual lawsuits filed within the MDL.

05.01.24

Special Master to be appointed in MDL

Discussions about appointing a Special Master to the lawsuit continued. A Special Master is a neutral person appointed by the court to help manage the complex proceedings. Professor Maura Grossman was appointed Special Master on Electronically Stored Information (ESI) discovery disputes for MDL No. 3060.

04.01.24

FDA missed deadline on formaldehyde ban

The FDA missed its April 2024 deadline for the proposed formaldehyde ban on hair straightening products. 

11.01.23

Subsidiaries dismissed from MDL

Two subsidiaries of Dabur India were dismissed for lack of personal jurisdiction in the United States. Three subsidiaries of Dabur India were originally included in the MDL. Only Namaste Laboratories remains on the list of defendants.

11.01.23

Claim filed to include Revlon in MDL

The Plaintiffs’ Steering Committee filed a claim to loop Revlon into the MDL. Revlon manufactures, markets and sells hair relaxer products containing harmful chemicals. Revlon was not originally included in the MDL because the parent company, Revlon Inc., filed bankruptcy. The November claim required Revlon to include potential plaintiff compensation in its bankruptcy plan. 

10.01.23

FDA proposes formaldehyde ban

The FDA proposed a new ban on the use of formaldehyde and formaldehyde-releasing chemicals in hair relaxers. The proposed ban acknowledged the link between formaldehyde and serious illnesses, including cancer. The proposal targeted April 2024 for the ban.

08.01.23

Short Form Complaint approved in hair relaxer MDL

The U.S. District Court for the Northern District of Illinois Eastern Division approved a Short Form Complaint in the hair relaxer MDL. A Short Form Complaint is an abbreviated version of a legal complaint filed by an individual plaintiff. It contains the essential information connected to the MDL. This includes claims, allegations and damages. It also references the broad allegations common to all plaintiffs in the MDL. A Short Form Complaint addresses the unique aspects of each plaintiff’s case. However, it is still consistent with the primary issues of the MDL.

05.01.23

Master complaint filed in hair relaxer MDL

A new docket entry clarified the process for filing new cases. New complaints would be filed as a new case in the Northern District of Illinois. Each would receive a unique docket number. The complaint had to include a district’s civil cover sheet connecting the new case with the MDL. The Court’s Clerk’s Office was made responsible for transferring the newly filed case to the MDL.

05.01.23

New process for filing cases in hair relaxer MDL

The formal Master Complaint was submitted in federal court. The Master Complaint consolidated the individual complaints and outlined the common allegations. 

03.01.23

Motley Rice attorney appointed co-lead counsel

Motley Rice attorney Fidelma Fitzpatrick was appointed as co-lead counsel for the hair relaxer MDL. A Plaintiff’s Steering Committee (PSC) was nominated. This was because the MDL had several law firms representing the various plaintiffs. The PSC would communicate with the court on behalf of all the plaintiffs. Fitzpatrick and their co-leads would preside over the actions of the PSC.

02.01.23

MDL approved for hair relaxer lawsuits

The MDL for hair relaxer marketing, sales practices and products liability litigation was officially approved. It was assigned to the Northern District of Illinois. Plaintiffs were looking for justice and compensation for their injuries caused by hair relaxer products. U.S. District Judge Mary M. Rowland was assigned to the hair relaxer MDL.

01.01.23

Hearing held over hair relaxer lawsuit consolidation

The Judicial Panel on Multidistrict Litigation (JPML) held a hearing to determine if the lawsuits will consolidate. The defendants opposed the consolidation. But plaintiffs were optimistic the hearing would have a favorable outcome. The Panel made no formal decision. 

12.01.22

Hearing set for potential hair relaxer MDL

The Judicial Panel on Multidistrict Litigation set a hearing date for January 2023. The hearing was for the motion to consolidate the lawsuits into an MDL. During the hearing, the defendants could voice their objections to the MDL.

12.01.22

Defendants argue against hair relaxer lawsuit consolidation

The defendants, including L’Oréal, argued against the consolidated MDL. The opposition to the MDL would be reviewed by the Judicial Panel on Multidistrict Litigation. 

11.01.22

Class action lawsuit filed against hair relaxer companies

A class action lawsuit was filed against L’Oréal and other hair relaxer companies . This separate case was also filed in the Northern District Court of Illinois. The plaintiffs were seeking restitution for the full purchase price of the products they purchased. The products include hair straighteners and relaxers made by L’Oréal and others. These companies allegedly didn’t disclose that their products contained dangerous endocrine-disrupting chemicals.

11.01.22

More hair relaxer lawsuits filed

After the initial hair relaxer lawsuit, more lawsuits were filed in nineteen districts . Attorneys representing the plaintiffs filed a motion to consolidate the related lawsuits into an MDL. With an MDL, similar cases could be transferred to a single district court. An MDL would streamline discovery, combine resources and help with consistency in pre-trial rulings. 

10.24.22

Hair relaxer lawsuit filed against L’Oréal

A 32-year-old woman filed a lawsuit in Illinois against L’Oréal and other companies . Her lawsuit claimed that long-term use of hair-straightening products caused her uterine cancer. The lawsuit alleged that L’Oréal and the other named companies marketed their products as safe and did not warn customers about the increased risk of cancer.

10.17.22

NIH study links hair relaxers and uterine cancer

The National Institutes of Health did a study using data from the Sister Study. They concluded that women who use hair-straightening products have a higher risk for uterine cancer than women who don’t . Using the products more than four times a year doubled their risk of developing uterine cancer.

This study added compelling evidence linking the increase in hormone-related cancers to toxic hair relaxers. This study was released days after the original lawsuits for hair relaxers were filed in Illinois.

09.01.21

New study points to link between ovarian cancer and hair relaxers

The peer-reviewed medical journal Carcinogenesis published an article in September 2021 about a study that links hair products to increased ovarian cancer risk. The study used data collected by the Sister Study over 10 years. They connected frequent use of hair straightener and relaxer products with an increased risk of ovarian cancer. 

View Full Timeline

Frequently asked questions (FAQs) about hair relaxer cancer lawsuits

When will the hair relaxer lawsuit be settled?

No hair relaxer lawsuit settlements have happened yet. The first hair relaxer lawsuit trials in the hair relaxer MDL – known as bellwether trials – have not yet begun.

With over 10,000 pending actions as of June 2, 2025, many parties are eager for trial dates to be set. Plaintiffs and defendants are currently involved in preparation, discovery and procedural motions. 

Motley Rice’s experience litigating defective products impacting women

If you or a loved one has been diagnosed with a reproductive cancer, we understand how challenging this time can be. Motley Rice is committed to helping those who have suffered life-altering health problems after using dangerous products. Our attorneys have led litigation brought by thousands of women harmed by defective products.

In the past, we’ve worked with people who have suffered major health issues as a result of defective products, such as:

  • Developed ovarian cancer after using talc-based baby powder
  • Suffered breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) allegedly caused by Allergan implants
  • Endured severe complications allegedly caused by birth control devices such as Essure® and Paragard® and complications arising from the use of transvaginal mesh
  • Women who had children with birth defects as a result of prescription drugs and necrotizing enterocolitis (NEC)

If you or a loved one was diagnosed with uterine, endometrial or ovarian cancer after using chemical hair straighteners, consider discussing your options with an attorney who has experience with multidistrict litigation and toxic exposure matters. Litigation with multiple defendants and thousands of plaintiffs is very complex.

Read more on our women's health litigation experience.

Why are people filing hair relaxer cancer lawsuits?

Predatory marketing efforts of hair relaxer companies

Companies and products named in hair relaxer cancer lawsuits

The alleged link between hair relaxers and cancer

Hair relaxers and uterine and endometrial cancer

Hair relaxers and ovarian cancer

Hair relaxer lawsuit update timeline

Frequently asked questions (FAQs) about hair relaxer cancer lawsuits

Motley Rice’s experience litigating defective products impacting women

About the Authors

Sources
  1. American Cancer Society. Formaldehyde and Cancer Risk.
  2. Chang CJ, O’Brien KM, Keil AP, Gaston SA, Jackson CL, Sandler DP, et al. Use of straighteners and other hair products and incident uterine cancer. JNCI: Journal of the National Cancer Institute. 2022 Dec 8;114(12):1636–45.
  3. Cleveland Clinic. Uterine Cancer (Endometrial Cancer).
  4. Journal of the National Cancer Institute: “Endocrine-disrupting chemicals in hair relaxers and reproductive cancer risks 2024.” DOI: 10.1093/jnci/djaa123.
  5. Justia. In Re: Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation.
  6. Justia. In Re: Hair Relaxer Marketing, Sales, Practices, And Products Liability Litigation No. 1:2023cv00818 - Document 291 (N.D. Ill. 2023).
  7. Justia. Mitchell v. L’Oreal USA, Inc et al.
  8. La Merrill MA, Vandenberg LN, Smith MT, Goodson W, Browne P, Patisaul HB, et al. Consensus on the key characteristics of endocrine-disrupting chemicals as a basis for hazard identification. Nat Rev Endocrinol. 2020 Jan;16(1):45–57.
  9. Mayo Clinic. Endometrial cancer.
  10. Mayo Clinic. Ovarian cancer.
  11. National Institutes of Health. Hair straightening chemicals associated with higher uterine cancer risk.
  12. NPR. FDA move to ban formaldehyde in hair straighteners called too little, too late.
  13. Reuters. Dabur India's two units dismissed as defendants in hair relaxer lawsuit in US.
  14. United States Judicial Panel on Multidistrict Litigation. About the Panel.
  15. Judicial Panel on Multidistrict Litigation. Pending MDLs.
  16. White AJ, Sandler DP, Gaston SA, Jackson CL, O’Brien KM. Use of hair products in relation to ovarian cancer risk. Carcinogenesis. 2021 Oct 5;42(9):1189–95.
Your Legal Options

Start Your Motley Rice Consultation in Simple Steps

Connect with an Attorney1.800.768.4026

1

Submit Information

Call us or fill out our online form with the details of your potential case.

2

Case Review

Our team reviews your information to assess your potential case.

3

Case Consultation

Talk with us about next steps.